Effect of Intravitreal Bevacizumab on Visual Acuity and Optical Coherence Tomography (Oct) Changes in Wet Age-Related Macular Degeneration

Journal of Evidence Based Medicine and Healthcare
doi 10.18410/jebmh/2019/467
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Level Up Business Center

Related search

Spectral-Domain Optical Coherence Tomography Imaging of Age-Related Macular Degeneration

US Ophthalmic Review
2011English

Optical Coherence Tomography for the Monitoring of Neovascular Age-Related Macular Degeneration

Ophthalmology
Ophthalmology
2015English

Spectral-Domain Optical Coherence Tomography Characteristics of Intermediate Age-Related Macular Degeneration

Ophthalmology
Ophthalmology
2013English

Optical Coherence Tomography-Based Deep-Learning Models for Classifying Normal and Age-Related Macular Degeneration and Exudative and Non-Exudative Age-Related Macular Degeneration Changes

Ophthalmology and Therapy
Ophthalmology
2019English

Focal Macular Electroretinograms After Intravitreal Injections of Bevacizumab for Age-Related Macular Degeneration

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2012English

Comparison of Fundus Fluorescein Angiography and Optical Coherence Tomography in Age-Related Macular Degeneration

Journal of Evidence Based Medicine and Healthcare
2016English

Quantitative Optical Coherence Tomography Findings in Various Subtypes of Neovascular Age-Related Macular Degeneration

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2008English

Intravitreal Bevacizumab vs Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration

Archives of Ophthalmology
2007English

Off-Label Use of Bevacizumab for Wet Age-Related Macular Degeneration in Europe

Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy